Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$12.42 - $17.29 $310 - $432
-25 Reduced 1.41%
1,750 $27,000
Q4 2023

Feb 13, 2024

SELL
$11.13 - $15.78 $545 - $773
-49 Reduced 2.69%
1,775 $26,000
Q3 2023

Nov 13, 2023

SELL
$16.15 - $42.35 $2,034 - $5,336
-126 Reduced 6.46%
1,824 $29,000
Q2 2023

Aug 04, 2023

BUY
$40.29 - $82.51 $16,639 - $34,076
413 Added 26.87%
1,950 $80,000
Q1 2023

May 12, 2023

SELL
$56.44 - $118.81 $2,539 - $5,346
-45 Reduced 2.84%
1,537 $92,000
Q4 2022

Feb 10, 2023

SELL
$63.98 - $85.37 $2,303 - $3,073
-36 Reduced 2.22%
1,582 $116,000
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $339 - $447
5 Added 0.31%
1,618 $123,000
Q2 2022

Aug 12, 2022

SELL
$56.6 - $89.9 $18,734 - $29,756
-331 Reduced 17.03%
1,613 $112,000
Q1 2022

May 13, 2022

BUY
$60.15 - $84.52 $60 - $84
1 Added 0.05%
1,944 $161,000
Q4 2021

Feb 11, 2022

SELL
$75.08 - $121.99 $5,030 - $8,173
-67 Reduced 3.33%
1,943 $146,000
Q3 2021

Nov 12, 2021

SELL
$116.17 - $194.55 $17,774 - $29,766
-153 Reduced 7.07%
2,010 $234,000
Q2 2021

Aug 13, 2021

SELL
$130.4 - $225.58 $12,518 - $21,655
-96 Reduced 4.25%
2,163 $480,000
Q1 2021

May 07, 2021

SELL
$124.11 - $190.17 $33,633 - $51,536
-271 Reduced 10.71%
2,259 $299,000
Q4 2020

Feb 12, 2021

SELL
$112.16 - $174.14 $7,851 - $12,189
-70 Reduced 2.69%
2,530 $438,000
Q3 2020

Nov 04, 2020

SELL
$58.05 - $111.31 $6,907 - $13,245
-119 Reduced 4.38%
2,600 $289,000
Q2 2020

Aug 12, 2020

SELL
$57.2 - $74.41 $2.79 Million - $3.62 Million
-48,709 Reduced 94.71%
2,719 $161,000
Q1 2020

May 04, 2020

SELL
$57.05 - $95.75 $169,552 - $284,569
-2,972 Reduced 5.46%
51,428 $3.46 Million
Q4 2019

Feb 05, 2020

SELL
$68.3 - $93.8 $31,213 - $42,866
-457 Reduced 0.83%
54,400 $4.58 Million
Q3 2019

Nov 08, 2019

BUY
$61.86 - $97.8 $60,251 - $95,257
974 Added 1.81%
54,857 $4.1 Million
Q2 2019

Aug 23, 2019

BUY
$42.22 - $63.23 $2.27 Million - $3.41 Million
53,883 New
53,883 $3.41 Million
Q2 2019

Aug 13, 2019

SELL
$42.22 - $63.23 $1.98 Million - $2.97 Million
-46,930 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$31.96 - $56.12 $48,643 - $85,414
-1,522 Reduced 3.14%
46,930 $2.26 Million
Q4 2018

Feb 13, 2019

SELL
$28.72 - $52.63 $10,712 - $19,630
-373 Reduced 0.76%
48,452 $1.62 Million
Q3 2018

Nov 09, 2018

BUY
$32.0 - $52.4 $64,576 - $105,743
2,018 Added 4.31%
48,825 $2.56 Million
Q2 2018

Aug 08, 2018

BUY
$19.85 - $32.0 $186,153 - $300,096
9,378 Added 25.06%
46,807 $1.47 Million
Q1 2018

May 07, 2018

SELL
$19.3 - $23.65 $28,506 - $34,931
-1,477 Reduced 3.8%
37,429 $816,000
Q4 2017

Feb 09, 2018

BUY
$16.3 - $21.9 $2,999 - $4,029
184 Added 0.48%
38,906 $786,000
Q3 2017

Nov 09, 2017

BUY
$18.05 - $21.75 $698,932 - $842,203
38,722
38,722 $769,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.